Tonix Pharmaceuticals
TNXP
#9180
Rank
NZ$0.27 B
Marketcap
NZ$17.07
Share price
-6.97%
Change (1 day)
-77.03%
Change (1 year)

Earnings for Tonix Pharmaceuticals (TNXP)

Earnings in 2026 (TTM): -NZ$0.26 Billion

According to Tonix Pharmaceuticals's latest financial reports the company's current earnings are NZ$17.55 Million. In 2025 the company made an earning of -NZ$0.21 Billion a decrease over its 2024 earnings that were of -NZ$0.13 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Tonix Pharmaceuticals from 2008 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$0.26 Billion20.8%
2025 -NZ$0.21 Billion61.37%
2024 -NZ$0.13 Billion-36.5%
2023 -NZ$0.21 Billion5.61%
2022 -NZ$0.2 Billion21.43%
2021 -NZ$0.16 Billion82.76%
2020 -NZ$87.26 Million75.22%
2019 -NZ$49.8 Million9.52%
2018 -NZ$45.47 Million23.63%
2017 -NZ$36.78 Million-45.36%
2016 -NZ$67.32 Million-19.09%
2015 -NZ$83.2 Million74.15%
2014 -NZ$47.78 Million153.99%
2013 -NZ$18.81 Million
2011 -NZ$9.08 Million29538.74%
2010 -NZ$0.04 Million-42.58%
2009 -NZ$0.06 Million46.05%
2008 -NZ$0.04 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Aerie Pharmaceuticals
AERI
-NZ$40.15 Million-84.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Eagle Pharmaceuticals
EGRX
NZ$61.59 M-124.14%๐Ÿ‡บ๐Ÿ‡ธ USA